Talk to sales Try for Free
Luisa M Stamm, MD, PhD

Luisa M Stamm, MD, PhD

Fulbright Scholar

Followers of Luisa M Stamm, MD, PhD1000 followers
location of Luisa M Stamm, MD, PhDSan Francisco Bay Area

Connect with Luisa M Stamm, MD, PhD to Send Message

Connect

Connect with Luisa M Stamm, MD, PhD to Send Message

Connect

  • Timeline

  • About me

    Associate Vice President, Infectious Disease Clinical Research | Section Head for HIV

  • Education

    • Harvard University

      1996 - 1998
      BA Biochemistry

    • University of California, San Francisco

      1999 - 2007
      Doctor of Medicine (MD)

    • University of California, San Francisco

      1999 - 2005
      PhD Biomedical Sciences

    • Amherst College

      1994 - 1995

  • Experience

    • Fundação Nacional de Saúde-FUNASA

      Jan 1998 - Jan 1999
      Fulbright Scholar

    • Brigham and Women's Hospital

      Jan 2007 - Jan 2009
      Internal Medicine Intern and Resident

    • Massachusetts General Hospital

      Jan 2009 - Jul 2013
      Clinical and Research Fellow in Infectious Disease

    • Harvard Medical School

      Jan 2013 - Jul 2013
      Instructor in Medicine

    • Gilead Sciences

      Jul 2013 - Nov 2019

      Senior member of the HCV and HIV Clinical Research teams with direct responsibility for the overall clinical research strategy and development activities. Directed development of sofosbuvir-containing regimens (Sovaldi, Harvoni, Epclusa and Vosevi), including Phase 1, 2 and 3 clinical studies and global registrational filings. Led the project team for development of broadly neutralizing antibodies for HIV cure.

      • Executive Director, Clinical Research

        Nov 2018 - Nov 2019

      • Senior Director, Clinical Research

        Aug 2018 - Nov 2018

      • Director, Clinical Research

        Feb 2016 - Jul 2018

      • Associate Director, Clinical Research

        Jul 2013 - Jan 2016

    • Assembly Biosciences, Inc.

      Nov 2019 - Aug 2022
      Chief Medical Officer

      Key member of the Executive Management team providing leadership and strategic direction for the company’s pipeline of programs for HBV cure and other viruses. Head of the Development organization, including Clinical Research, Operations, Regulatory Affairs, and Biometrics. Led the execution of the clinical plans for 4 HBV core inhibitors in Phase 1 and Phase 2 studies as monotherapy and in combination with other approved and investigational agents.

    • Bill & Melinda Gates Medical Research Institute

      Mar 2023 - Apr 2024
      Clinical Development Leader

      Leading the clinical planning and trial execution for a novel quadrivalent oligosaccharide-based vaccine targeting Shigella, a long-acting monoclonal to RSV for use in low- and middle-income countries and next-generation regimens for treatment of tuberculosis.

    • Merck

      Apr 2024 - now
      Associate Vice President, Infectious Disease Clinical Research | Section Head for HIV

  • Licenses & Certifications

    • Subspecialty Certification in Infectious Disease

      American Board of Internal Medicine

    • Certification in Internal Medicine

      American Board of Internal Medicine